- Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
- Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
- Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer
Key statistics
On Monday, Immutep Ltd (YP1B:STU) closed at 0.284, -2.07% below its 52-week high of 0.29, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.284 |
---|---|
High | 0.284 |
Low | 0.284 |
Bid | 0.278 |
Offer | 0.302 |
Previous close | 0.268 |
Average volume | 0.00 |
---|---|
Shares outstanding | 1.19bn |
Free float | 1.14bn |
P/E (TTM) | -- |
Market cap | 540.92m AUD |
EPS (TTM) | -0.0394 AUD |
Data delayed at least 15 minutes, as of May 20 2024.
More ▼